• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Toolbar - View Selection
 
Items 1 of 1
ALX-430-015 Revised 18-Feb-08
MAHMA NONOate
Add to Clipboard
SYNONYMS NOC-9
MAHMA/NO
(Z)-1-(N-Methyl-N-[6-(N-methylammoniohexyl)amino])-diazen-1-ium-1,2-diolate
PRODUCT LINE Nitric Oxide Pathway
PRODUCT CATEGORY Nitric Oxide Donors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-430-015-M005   5 mg 30.00 USD Add To Cart
ALX-430-015-M025   25 mg 100.00 USD Add To Cart
ALX-430-015-5005   5x5 mg 120.00 USD Add To Cart
Product Specification
FORMULA: C8H20N4O2
MW: 204.3
CAS NUMBER: 146724-86-9
PURITY: ≥97% (HPLC)
APPEARANCE: White to off-white crystalline solid.
SOLUBILITY: Soluble in water.
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: -20°C
USE/STABILITY: Relatively stable in alkaline solution.
HANDLING: Protect from light and moisture.
HAZARD: IRRITANT.
Product Description
Nitric oxide (NO) donor. The half-life time of MAHMA NONOate is 2.7 min. at 22°C in 0.1M phosphate buffer, pH 7.4. Decomposition of NONOates is nearly instantaneous at pH 5.0.
Product Specific Literature References
New nitric oxide-releasing zwitterions derived from polyamines: J.A. Hrabie, et al.; J. Org. Chem. 58, 1472 (1993)
Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate: K.L. Homer & J.C. Wanstall; Br. J. Pharmacol. 137, 1071 (2002) Abstract
Platelet inhibitory effects of the nitric oxide donor drug MAHMA NONOate in vivo in rats: K.L. Homer & J.C. Wanstall; Eur. J. Pharmacol. 482, 265 (2003) Abstract
Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT): L.J. Bryan-Lluka, et al.; Br. J. Pharmacol. 143, 63 (2004) Abstract
 
 

Your items will be kept only for the duration of your visit.